Sex-related psychological predictors of baseline pain perception and analgesic responses to pentazocine.
Sex differences in pain perception and analgesic responses have garnered increasing attention in recent years. We examined the association of psychological factors to baseline pain perception and pentazocine analgesia among 49 healthy women and 39 men. Subjects completed psychological questionnaires measuring positive and negative affect as well as catastrophizing. Subsequently, responses to experimental pain were assessed before and after double-blind administration of intravenous pentazocine (0.5mg/kg). In correlational analyses, positive affect predicted lower pain sensitivity among men but not women. Negative affect predicted lower baseline pain tolerances among both sexes but predicted poorer analgesia only among men. Catastrophizing was associated with greater pain sensitivity and less analgesia more consistently in men than women. Regression models revealed that positive affect predicted lower overall pain sensitivity and catastrophizing predicted poorer overall analgesic responses among men, while no significant predictors of overall pain or analgesia emerged for women. Moreover, positive affect and catastrophizing were negatively and positively correlated, respectively, with side effects from the medication, but only among men. These findings indicate sex-dependent associations of psychological factors with baseline pain perception, analgesic responses, and medication side effects.
Fillingim
Roger B
RB
University of Florida College of Dentistry, Public Health Services and Research, 1600 SW Archer Road, Room D8-44A, P.O. Box 100404, Gainesville, FL 32610-0404, USA. rfillingim@dental.ufl.edu
Hastie
Barbara A
BA
Ness
Timothy J
TJ
Glover
Toni L
TL
Campbell
Claudia M
CM
Staud
Roland
R
D000328:Adult; D000701:Analgesics, Opioid / Q000494:pharmacology*; D001143:Arousal / Q000187:drug effects; D003863:Depression / Q000503:physiopathology / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007206:Individuality; D007262:Infusions, Intravenous; D008297:Male; D010147:Pain Measurement; D017288:Pain Threshold / Q000187:drug effects*; D010423:Pentazocine / Q000494:pharmacology*; D011379:Prognosis; D012307:Risk Factors; D012737:Sex Factors; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D010423:Pentazocine